| Market Cap | ₹962Cr |
| ROE | 11.18% |
| P/E Ratio(TTM) | 12.03 |
| EPS(TTM) | 39.94 |
| P/B Ratio | 1.34 |
| Dividend Yield | 0.37% |
| Industry P/E | 33.14 |
| Book Value | 357.35 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Lincoln Pharmaceuticals Ltd |
| Managing Director | Mr. Mahendra G. Patel |
| Founded | 1979 |
| NSE Symbol | LINCOLN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.30 | ||
| Ajanta Pharma | NA (0.00%) | 34.40 | ||
| Gland Pharma | NA (0.00%) | 34.47 | ||
| Eris Lifesciences | NA (0.00%) | 46.30 |